According to Inside INdiana Business, Indianapolis-based Eli Lilly and Company will present 14 studies involving its osteoporosis medications at the American Society for Bone and Mineral Research annual meeting, which begins today in Toronto, Ontario, Canada. The drugmaker will share data about Forteo and Evista..
No comments:
Post a Comment